Colgate-Palmolive Co. (NYSE:CL) shares reached a new 52-week high on Thursday . The company traded as high as $75.33 and last traded at $74.72, with a volume of 2,876,122 shares changing hands. The stock had previously closed at $74.47.

A number of research firms have weighed in on CL. B. Riley reissued a “neutral” rating and issued a $71.00 target price on shares of Colgate-Palmolive in a report on Wednesday, May 4th. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 target price on the stock in a report on Monday, May 9th. Goldman Sachs Group Inc. raised Colgate-Palmolive from a “sell” rating to a “neutral” rating and increased their target price for the company from $62.00 to $75.00 in a report on Monday, May 2nd. Morgan Stanley reissued a “hold” rating on shares of Colgate-Palmolive in a report on Friday, April 29th. Finally, Citigroup Inc. increased their target price on Colgate-Palmolive from $78.00 to $82.00 and gave the company a “buy” rating in a report on Thursday, April 14th. Eleven analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $72.75.

The company has a 50-day moving average price of $72.07 and a 200 day moving average price of $69.16. The company has a market capitalization of $66.60 billion and a PE ratio of 49.192.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Thursday, April 28th. The company reported $0.63 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.63. During the same period in the previous year, the company posted $0.66 EPS. The business earned $3.76 billion during the quarter, compared to analyst estimates of $3.76 billion. The business’s revenue for the quarter was down 7.6% compared to the same quarter last year. On average, equities analysts forecast that Colgate-Palmolive Co. will post $2.81 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 15th. Investors of record on Friday, July 22nd will be issued a $0.39 dividend. The ex-dividend date is Wednesday, July 20th. This represents a $1.56 dividend on an annualized basis and a yield of 2.09%.

In related news, CTO Patricia Verduin sold 3,666 shares of the company’s stock in a transaction dated Wednesday, June 15th. The stock was sold at an average price of $72.19, for a total value of $264,648.54. Following the completion of the transaction, the chief technology officer now owns 54,602 shares of the company’s stock, valued at approximately $3,941,718.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Victoria L. Dolan sold 19,334 shares of the company’s stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $71.76, for a total value of $1,387,407.84. Following the completion of the transaction, the vice president now directly owns 55,526 shares of the company’s stock, valued at approximately $3,984,545.76. The disclosure for this sale can be found here.

Other institutional investors have added to or reduced their stakes in the company. Gulf International Bank UK Ltd boosted its position in Colgate-Palmolive by 2.3% in the fourth quarter. Gulf International Bank UK Ltd now owns 253,548 shares of the company’s stock worth $16,891,000 after buying an additional 5,800 shares during the last quarter. Stevens Capital Management LP acquired a new position in Colgate-Palmolive during the fourth quarter worth $18,065,000. Artemis Investment Management LLP boosted its position in Colgate-Palmolive by 19.8% in the fourth quarter. Artemis Investment Management LLP now owns 185,057 shares of the company’s stock worth $12,326,000 after buying an additional 30,535 shares during the last quarter. Verity & Verity LLC boosted its position in Colgate-Palmolive by 14.0% in the fourth quarter. Verity & Verity LLC now owns 32,022 shares of the company’s stock worth $2,133,000 after buying an additional 3,923 shares during the last quarter. Finally, Vaughan David Investments Inc. IL boosted its position in Colgate-Palmolive by 0.3% in the fourth quarter. Vaughan David Investments Inc. IL now owns 266,780 shares of the company’s stock worth $17,773,000 after buying an additional 900 shares during the last quarter.

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.